A purpose-built AI platform connecting commercial strategy, scientific communications, omnichannel execution, and performance analytics. In one system. Built by people who have spent 20+ years inside pharma commercialization.
Eight years running OVYN in production across three verticals.
97.5% MLR pre-check pass rate across regulated workloads.
4–6 weeks from kickoff to live connector flow.
Pharma and biotech brands are running fragmented commercial operations: multiple agencies, disconnected workflows, generic AI tools that weren’t built for regulated markets. They’re paying for speed and not getting it.
The agencies serving them have the same problem from the other side: capacity constraints, compliance overhead, margin pressure.
Strategy, content, channel, and signal share state and travel together. Not four tools stitched at the edges. Compliance is the spine all four rest on.
HCP segmentation, payer landscape, competitive signal, audience behaviour. The strategic spine the rest of the system runs on.
Scientific and brand content, MLR-aware from the first draft, modular and versioned by channel. One clinical truth, every downstream touchpoint.
HCP digital, patient and caregiver, congress, MSL, field force. Coordinated from one execution layer instead of three agency reporting lines.
Engagement depth, reach by segment, channel performance, updated continuously. Built to be acted on, not archived in a quarterly deck.
Scientific, medical, legal, regulatory, approval, channel deployment. With claim provenance and audit trail wired into how each piece is structured, not bolted on at the gate.
Submitted for medical, legal, and regulatory review. Each reviewer gets only the section they own. Returns surface as claim-level edits, not whole-piece rewrites.
Every claim references its source. Revisions re-enter review at the state they changed. Not from the top. The audit trail is how content moves, not something added at the gate.
OVYN reads from the systems pharma already runs and writes back to the surfaces brands already execute on. Strategy and content live in OVYN; CRM, MA, congress, and field tooling stay where they are.
Reads from clinical trials, payer & access data, HCP behavioural signal, real-world evidence, the brand’s claims library.
Writes to CRM, marketing automation, congress & MSL tooling, patient surfaces, MLR archive.
Categories, not vendor lock-in. OVYN plugs into the systems your brand already pays for. Specific integrations are scoped during the working session.
Each connector is scoped and built during onboarding, against your tenant of the systems your brand already runs. 4–6 weeks from kickoff to live signal flow. Identity providers wire in natively from day one.
Pick the engagement shape that fits where your team is. We’ve built it three ways. The platform stays the same; what changes is how much of it we run for you.
Ephicacy Health operates the platform on your brand. Strategy, content, MLR, omnichannel, analytics. We run all of it with your team in the loop.
Your team operates the platform. We provide onboarding, connectors, and ongoing platform support. For large pharma and agencies running multiple brands at once.
Co-operated. Your team owns brand and review. We run the platform plumbing, the MLR rail, and the analytics layer. Lift-and-shift handover available at any phase.
The same architecture, adapted to the regulatory and commercial reality of each market. Pharma rigor at the top of the spectrum, consumer credibility at the bottom. The platform shifts what it shows you, not what it is.
Launch, lifecycle, MLR-aware end to end. Regulated workflow, audit trail, claim provenance baked into how content moves.
Hardware-plus-software brands. HCP onboarding, patient activation, post-market evidence, coordinated as one motion.
Clinical credibility meeting commercial activation. Multi-brand portfolios, performance health, regenerative medicine.
Science-backed wellness, supplements, DTC health. Healthcare marketing rigor. Not just consumer creativity.
Pharma brands hire OVYN. So do the agencies that serve them. Capacity constraints, compliance overhead, margin pressure. The structural pain mirrors on both sides of the brief. OVYN runs as a co-pilot or white-label layer inside your stack. Not in place of your team.
Strategic frameworks, content workflows, compliance logic, and measurement architecture are informed by 20+ years of real pharma commercialization. Not trained on generic internet data. And unlike a SaaS vendor, Ephicacy Health also runs the work: the platform and the operators arrive together.
M.E.Compliance is the architecture, not the gate. Audit trail and claim provenance belong in how content moves, not at the end of it.
Strategy travels with content. Strategy that doesn’t reach the work isn’t strategy. It’s a deck.
Live signal beats quarterly recaps. If you find out a campaign failed three months after it shipped, the campaign isn’t the problem.
Most pharma AI was retrofitted from outside the industry. We don’t think that’s a small detail.
A tool alone will not ship a launch. The operators arrive with the platform.
